SC 13G 1 srz9616472v2.txt VASO ACTIVE PHARMACEUTICALS, INC. SC 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 VASO ACTIVE PHARMACEUTICALS, INC. ------------------------------------------------------ (Name of Issuer) CLASS A COMMON STOCK ------------------------------------------------------ (Title of Class of Securities) 92232R107 ------------------------------------------------------ (CUSIP NUMBER) March 16, 2004 ------------------------------------------------------ (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [X] Rule 13d-1(c) [ ] Rule 13d-1(d) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the notes). Page 1 of 10 Pages CUSIP NO. 92232R107 13G Page 2 of 10 Pages (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) The Riverview Group LLC ----------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ** (a) [X] (b) [ ] ----------------------------------------------------------------------- (3) SEC USE ONLY ----------------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION Delaware ----------------------------------------------------------------------- NUMBER OF (5) SOLE VOTING POWER -0- SHARES ----------------------------------------------------------------------- BENEFICIALLY (6) SHARED VOTING POWER 643,574 OWNED BY ----------------------------------------------------------------------- EACH (7) SOLE DISPOSITIVE POWER -0- REPORTING ----------------------------------------------------------------------- PERSON WITH (8) SHARED DISPOSITIVE POWER 643,574 ----------------------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 643,574 ----------------------------------------------------------------------- (10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ** [ ] ----------------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.99% ----------------------------------------------------------------------- (12) TYPE OF REPORTING PERSON ** OO ----------------------------------------------------------------------- ** SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP NO. 92232R107 13G Page 3 of 10 Pages (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Millennium Holding Group, L.P. ----------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ** (a) [X] (b) [ ] ----------------------------------------------------------------------- (3) SEC USE ONLY ----------------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION Delaware ----------------------------------------------------------------------- NUMBER OF (5) SOLE VOTING POWER -0- SHARES ----------------------------------------------------------------------- BENEFICIALLY (6) SHARED VOTING POWER 643,574 OWNED BY ----------------------------------------------------------------------- EACH (7) SOLE DISPOSITIVE POWER -0- REPORTING ----------------------------------------------------------------------- PERSON WITH (8) SHARED DISPOSITIVE POWER 643,574 ----------------------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 643,574 ----------------------------------------------------------------------- (10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ** [ ] ----------------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.99% ----------------------------------------------------------------------- (12) TYPE OF REPORTING PERSON ** PN ----------------------------------------------------------------------- ** SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP NO. 92232R107 13G Page 4 of 10 Pages (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Millennium Management, LLC ----------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ** (a) [X] (b) [ ] ----------------------------------------------------------------------- (3) SEC USE ONLY ----------------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION Delaware ----------------------------------------------------------------------- NUMBER OF (5) SOLE VOTING POWER -0- SHARES ----------------------------------------------------------------------- BENEFICIALLY (6) SHARED VOTING POWER 643,574 OWNED BY ----------------------------------------------------------------------- EACH (7) SOLE DISPOSITIVE POWER -0- REPORTING ----------------------------------------------------------------------- PERSON WITH (8) SHARED DISPOSITIVE POWER 643,574 ----------------------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 643,574 ----------------------------------------------------------------------- (10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ** [ ] ----------------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.99% ----------------------------------------------------------------------- (12) TYPE OF REPORTING PERSON ** OO ----------------------------------------------------------------------- ** SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP NO. 92232R107 13G Page 5 of 10 Pages (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Israel A. Englander ----------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ** (a) [X] (b) [ ] ----------------------------------------------------------------------- (3) SEC USE ONLY ----------------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION United States ----------------------------------------------------------------------- NUMBER OF (5) SOLE VOTING POWER -0- SHARES ----------------------------------------------------------------------- BENEFICIALLY (6) SHARED VOTING POWER 643,574 OWNED BY ----------------------------------------------------------------------- EACH (7) SOLE DISPOSITIVE POWER -0- REPORTING ----------------------------------------------------------------------- PERSON WITH (8) SHARED DISPOSITIVE POWER 643,574 ----------------------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 643,574 ----------------------------------------------------------------------- (10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ** [ ] ----------------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.99% ----------------------------------------------------------------------- (12) TYPE OF REPORTING PERSON ** IN ----------------------------------------------------------------------- ** SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP NO. 92232R107 13G Page 6 of 10 Pages Item 1. (a) Name of Issuer Vaso Active Pharmaceuticals, Inc., a Delaware corporation (the "Company"). (b) Address of Issuer's Principal Executive Offices: 99 Rosewood Drive, Suite 260 Danvers, Massachusetts 01923 Item 2(a). Name of Person Filing Item 2(b). Address of Principal Business Office Item 2(c). Citizenship The Riverview Group LLC c/o Millennium Management, LLC 666 Fifth Avenue New York, New York 10103 Citizenship: Delaware Millennium Holding Group, L.P. c/o Millennium Management, LLC 666 Fifth Avenue New York, New York 10103 Citizenship: Delaware Millennium Management, LLC 666 Fifth Avenue New York, New York 10103 Citizenship: Delaware Israel A. Englander c/o Millennium Management, LLC 666 Fifth Avenue New York, New York 10103 Citizenship: United States (d) Title of Class of Securities Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") (e) CUSIP Number 92232R107 CUSIP NO. 92232R107 13G Page 7 of 10 Pages Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). If this statement is filed pursuant to Rule 13d-1(c), check this box. [X] Item 4. Ownership (a) Amount Beneficially Owned Subject to the Ownership Limitation (defined below), as of the date of this filing, each Reporting Person may be deemed the beneficial owner of: (i) 166,667 shares of Class A Common Stock currently issuable to The Riverview Group LLC, a Delaware limited liability company ("Riverview") upon the exercise of a certain warrant (the "Warrant") and (ii) 833,333 shares of Class A Common Stock currently issuable to Riverview upon the conversion of a certain 2% convertible note in the aggregate principal amount of $7,500,000 convertible into shares of Class A Common Stock at a conversion price of $9.00 (the "Convertible Note"). The number of shares of Class A Common Stock into which the Warrant and the Convertible Note are exercisable or convertible, as applicable, are limited pursuant to the terms of the Warrant and the Convertible Note to that number of shares of Class A Common Stock which would result in Riverview having aggregate beneficial ownership of not more than 9.99% of the total issued and outstanding shares of Class A Common Stock (the "Ownership Limitation"). Therefore, the percent of class beneficially owned by the Reporting Persons is limited to 9.99%. CUSIP NO. 92232R107 13G Page 8 of 10 Pages In accordance with the Ownership Limitation, as of the date of this filing, each Reporting Person may be deemed the beneficial owner of 643,574 shares of Class A Common Stock. (Based on the Securities Purchase Agreement, dated as of March 16, 2004, by and among the Company and Riverview, which was filed as Exhibit 4.1 to the Company's Form 8-K filed on March 17, 2004, there were 5,798,604 shares of Class A Common Stock issued and outstanding as of March 16, 2004. In addition, 643,574 shares of Class A Common Stock are currently issuable to Riverview pursuant to the terms of the Warrant and Convertible Note without causing Riverview's aggregate beneficial ownership to exceed the Ownership Limitation.) Note: The sole member of Riverview is Millenium Holding Group, L.P., a Delaware limited partnership ("Holding"). Millennium Management, LLC, a Delaware limited liability company ("Millennium Management"), is the general partner of Holding and consequently has voting control and investment discretion over securities owned by Holding and by Riverview. Israel A. Englander ("Mr. Englander") is the sole managing member of Millennium Management. As a result, Mr. Englander may be considered the beneficial owner of any shares deemed to be beneficially owned by Millennium Management. The foregoing should not be construed in and of itself as an admission by any of Holding, Millennium Management or Mr. Englander as to beneficial ownership of the shares owned by Riverview. Note: Millennium Partners, L.P., a Cayman Islands limited partnership ("Partners"), is a limited partner of Holding. As a limited partner, Partners has no investment or voting control over Holding or its securities positions. (b) Percent of Class 9.99% (see Item 4(a) above). (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: -0- (ii) Shared power to vote or to direct the vote 643,574 shares of Class A Common Stock (iii) Sole power to dispose or to direct the disposition of -0- (iv) Shared power to dispose or to direct the disposition of 643,574 shares of Class A Common Stock CUSIP NO. 92232R107 13G Page 9 of 10 Pages Item 5. Ownership of Five Percent or Less of a Class Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not applicable. Item 8. Identification and Classification of Members of the Group This statement is filed by: (i) Riverview; (ii) Holding, as the sole member of Riverview; (iii) Millennium Management, as the general partner of Holding; and (iv) Mr. Englander, as the sole managing member of Millennium Management. Item 9. Notice of Dissolution of Group Not applicable Item 10. Certification By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. CUSIP NO. 92232R107 13G Page 10 of 10 Pages SIGNATURE After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct. Dated: March 25, 2004 THE RIVERVIEW GROUP LLC MILLENNIUM HOLDING GROUP, L.P. By: Millennium Holding Group, L.P., By: Millennium Management, LLC its sole member its general partner By: Millennium Management, LLC By:/s/ Terry Feeney its general partner ------------------------------ Name: Terry Feeney By:/s/ Terry Feeney Title: Chief Operating Officer -------------------------------- Name: Terry Feeney Title: Chief Operating Officer MILLENNIUM MANAGEMENT, LLC By:/s/ Terry Feeney /s/ Israel A. Englander -------------------------------- --------------------------------- Name: Terry Feeney Israel A. Englander Title: Chief Operating Officer